Global Dermatology Diagnostic Devices and Therapeutics Report Thumbnail

Global Dermatology Diagnostic Devices and Therapeutics Market by Type (Dermatoscopes, Microscopes, Trichoscopes, Imaging Equipment, Antibacterial Agents, Antifungal Agents, Antiviral Agents, Corticosteroids, Retinoids, Immunosuppressants), By Application (Hospitals, Clinics, Research institutions) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: MDC-1227
  • Author: Up Market Research
  • Rating: 4.5
  • Total Reviews: 77
  • No. Of Pages: 204
  • Format:
  • Pub. Date: 2021-03-01
  • Share:

Up Market Research published a new report titled “Dermatology Diagnostic Devices and Therapeutics Market research report which is segmented by Types (Dermatoscopes, Microscopes, Trichoscopes, Imaging Equipment, Antibacterial Agents, Antifungal Agents, Antiviral Agents, Corticosteroids, Retinoids, Immunosuppressants), By Applications (Hospitals, Clinics, Research institutions), By Players/Companies Agfa, Astellas Pharma, Cutera, Dino-Lite, Galderma, Genentech, Stiefel, LEO Pharma, Michelson Diagnostics, Novartis, Bausch Health, Canfield Scientific”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.


Report Scope

Report AttributesReport Details
Report TitleDermatology Diagnostic Devices and Therapeutics Market Research Report
By TypeDermatoscopes, Microscopes, Trichoscopes, Imaging Equipment, Antibacterial Agents, Antifungal Agents, Antiviral Agents, Corticosteroids, Retinoids, Immunosuppressants
By ApplicationHospitals, Clinics, Research institutions
By CompaniesAgfa, Astellas Pharma, Cutera, Dino-Lite, Galderma, Genentech, Stiefel, LEO Pharma, Michelson Diagnostics, Novartis, Bausch Health, Canfield Scientific
Regions CoveredNorth America, Europe, APAC, Latin America, MEA
Base Year2020
Historical Year2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year2028
Number of Pages204
Number of Tables & Figures143
Customization AvailableYes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.


Global Dermatology Diagnostic Devices and Therapeutics Industry Outlook

Global Dermatology Diagnostic Devices and Therapeutics Market Report Segments:

The market is segmented by Type Dermatoscopes, Microscopes, Trichoscopes, Imaging Equipment, Antibacterial Agents, Antifungal Agents, Antiviral Agents, Corticosteroids, Retinoids, Immunosuppressants and By Application Hospitals, Clinics, Research institutions.


Some of the companies that are profiled in this report are:

  1. Agfa
  2. Astellas Pharma
  3. Cutera
  4. Dino-Lite
  5. Galderma
  6. Genentech
  7. Stiefel
  8. LEO Pharma
  9. Michelson Diagnostics
  10. Novartis
  11. Bausch Health
  12. Canfield Scientific

Dermatology Diagnostic Devices and Therapeutics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.


Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Dermatology Diagnostic Devices and Therapeutics Market

Overview of the regional outlook of the Dermatology Diagnostic Devices and Therapeutics Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.


Dermatology Diagnostic Devices and Therapeutics Market Overview

Highlights of The Dermatology Diagnostic Devices and Therapeutics Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Dermatology Diagnostic Devices and Therapeutics Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

                1. Dermatoscopes

                2. Microscopes

                3. Trichoscopes

                4. Imaging Equipment

                5. Antibacterial Agents

                6. Antifungal Agents

                7. Antiviral Agents

                8. Corticosteroids

                9. Retinoids

                10. Immunosuppressants

       7. By Application:

                1. Hospitals

                2. Clinics

                3. Research institutions

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Dermatology Diagnostic Devices and Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.


How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Dermatology Diagnostic Devices and Therapeutics Market Statistics

Reasons to Purchase the Dermatology Diagnostic Devices and Therapeutics Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dermatology Diagnostic Devices and Therapeutics Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Dermatology Diagnostic Devices and Therapeutics Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Dermatology Diagnostic Devices and Therapeutics Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Dermatology Diagnostic Devices and Therapeutics Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Dermatology Diagnostic Devices and Therapeutics Market Size & Forecast, 2018-2028 
      4.5.1 Dermatology Diagnostic Devices and Therapeutics Market Size and Y-o-Y Growth 
      4.5.2 Dermatology Diagnostic Devices and Therapeutics Market Absolute $ Opportunity 


Chapter 5 Global Dermatology Diagnostic Devices and Therapeutics Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Type
      5.2.1 Dermatoscopes
      5.2.2 Microscopes
      5.2.3 Trichoscopes
      5.2.4 Imaging Equipment
      5.2.5 Antibacterial Agents
      5.2.6 Antifungal Agents
      5.2.7 Antiviral Agents
      5.2.8 Corticosteroids
      5.2.9 Retinoids
      5.2.10 Immunosuppressants
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Dermatology Diagnostic Devices and Therapeutics Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Applications
      6.2.1 Hospitals
      6.2.2 Clinics
      6.2.3 Research institutions
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Dermatology Diagnostic Devices and Therapeutics Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Dermatology Diagnostic Devices and Therapeutics Analysis and Forecast
   9.1 Introduction
   9.2 North America Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Type
      9.6.1 Dermatoscopes
      9.6.2 Microscopes
      9.6.3 Trichoscopes
      9.6.4 Imaging Equipment
      9.6.5 Antibacterial Agents
      9.6.6 Antifungal Agents
      9.6.7 Antiviral Agents
      9.6.8 Corticosteroids
      9.6.9 Retinoids
      9.6.10 Immunosuppressants
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Applications
      9.10.1 Hospitals
      9.10.2 Clinics
      9.10.3 Research institutions
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Dermatology Diagnostic Devices and Therapeutics Analysis and Forecast
   10.1 Introduction
   10.2 Europe Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Type
      10.6.1 Dermatoscopes
      10.6.2 Microscopes
      10.6.3 Trichoscopes
      10.6.4 Imaging Equipment
      10.6.5 Antibacterial Agents
      10.6.6 Antifungal Agents
      10.6.7 Antiviral Agents
      10.6.8 Corticosteroids
      10.6.9 Retinoids
      10.6.10 Immunosuppressants
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Applications
      10.10.1 Hospitals
      10.10.2 Clinics
      10.10.3 Research institutions
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Dermatology Diagnostic Devices and Therapeutics Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Type
      11.6.1 Dermatoscopes
      11.6.2 Microscopes
      11.6.3 Trichoscopes
      11.6.4 Imaging Equipment
      11.6.5 Antibacterial Agents
      11.6.6 Antifungal Agents
      11.6.7 Antiviral Agents
      11.6.8 Corticosteroids
      11.6.9 Retinoids
      11.6.10 Immunosuppressants
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Applications
      11.10.1 Hospitals
      11.10.2 Clinics
      11.10.3 Research institutions
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Dermatology Diagnostic Devices and Therapeutics Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Type
      12.6.1 Dermatoscopes
      12.6.2 Microscopes
      12.6.3 Trichoscopes
      12.6.4 Imaging Equipment
      12.6.5 Antibacterial Agents
      12.6.6 Antifungal Agents
      12.6.7 Antiviral Agents
      12.6.8 Corticosteroids
      12.6.9 Retinoids
      12.6.10 Immunosuppressants
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Applications
      12.10.1 Hospitals
      12.10.2 Clinics
      12.10.3 Research institutions
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Dermatology Diagnostic Devices and Therapeutics Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Type
      13.6.1 Dermatoscopes
      13.6.2 Microscopes
      13.6.3 Trichoscopes
      13.6.4 Imaging Equipment
      13.6.5 Antibacterial Agents
      13.6.6 Antifungal Agents
      13.6.7 Antiviral Agents
      13.6.8 Corticosteroids
      13.6.9 Retinoids
      13.6.10 Immunosuppressants
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Applications
      13.10.1 Hospitals
      13.10.2 Clinics
      13.10.3 Research institutions
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Dermatology Diagnostic Devices and Therapeutics Market: Competitive Dashboard
   14.2 Global Dermatology Diagnostic Devices and Therapeutics Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Agfa
      14.3.2 Astellas Pharma
      14.3.3 Cutera
      14.3.4 Dino-Lite
      14.3.5 Galderma
      14.3.6 Genentech
      14.3.7 Stiefel
      14.3.8 LEO Pharma
      14.3.9 Michelson Diagnostics
      14.3.10 Novartis
      14.3.11 Bausch Health
      14.3.12 Canfield Scientific
Segments Covered in the Report
The global Dermatology Diagnostic Devices and Therapeutics market has been segmented based on

By Types
  • Dermatoscopes
  • Microscopes
  • Trichoscopes
  • Imaging Equipment
  • Antibacterial Agents
  • Antifungal Agents
  • Antiviral Agents
  • Corticosteroids
  • Retinoids
  • Immunosuppressants
By Applications
  • Hospitals
  • Clinics
  • Research institutions
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Agfa
  • Astellas Pharma
  • Cutera
  • Dino-Lite
  • Galderma
  • Genentech
  • Stiefel
  • LEO Pharma
  • Michelson Diagnostics
  • Novartis
  • Bausch Health
  • Canfield Scientific

Buy Report